Exciting new publication from EpiEndo staff and collaborators

Our team of scientists have published their findings on the global changes Azithromycin (Azm) causes in the gene expression of the bronchial epithelium.

Taken together, we demonstrate how Azm might confer its barrier enhancing effects, via activation of epidermal characteristics and changes to extracellular lipid dynamics. These effects of Azm could explain the unexpected clinical benefit observed during Azm-treatment of patients with various lung diseases affecting barrier function.

You can read the whole publication here: